Shares of Amicus Therapeutics Inc. (Nasdaq: FOLD) continued soaring by gaining 64 cents to close at $6.84 after reporting successful late stage trial results last week.
Amicus Therapeutics continues soaring
August 27, 2014 at 17:30 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|